RATIONALE: Glyceryl trinitrate, a nitric oxide donor, is a candidate treatment for acute stroke; it lowers blood pressure, does not alter cerebral blood flow or platelet function and is neuroprotective in experimental stroke. The ongoing rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial aims to assess the safety and efficacy of paramedic-delivered glyceryl trinitrate in patients with ultra-acute stroke.Aims and design: The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is a multicentre UK-based prospective randomised sham-controlled outcome-blinded parallel-group trial in patients with presumed stroke who present to the ambulance service following a 999 emergency call. The primary outcome is the modified Rankin scale measured by central telephone follow-up at 90 days. RESULTS: This paper describes the statistical analysis plan for the rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial and was developed prior to unblinding to treatment allocation. The statistical analysis plan includes details of methods for analyses and unpopulated tables and figures to be included in the primary and other secondary publications. DISCUSSION: Statistical analysis plan details what analyses will be done prior to unblinding to treatment allocation to avoid bias in the findings. Rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial will determine whether glyceryl trinitrate administered ultra-acutely can improve outcome after stroke. The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is registered as ISRCTN26986053.
RATIONALE: Glyceryl trinitrate, a nitric oxide donor, is a candidate treatment for acute stroke; it lowers blood pressure, does not alter cerebral blood flow or platelet function and is neuroprotective in experimental stroke. The ongoing rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial aims to assess the safety and efficacy of paramedic-delivered glyceryl trinitrate in patients with ultra-acute stroke.Aims and design: The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is a multicentre UK-based prospective randomised sham-controlled outcome-blinded parallel-group trial in patients with presumed stroke who present to the ambulance service following a 999 emergency call. The primary outcome is the modified Rankin scale measured by central telephone follow-up at 90 days. RESULTS: This paper describes the statistical analysis plan for the rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial and was developed prior to unblinding to treatment allocation. The statistical analysis plan includes details of methods for analyses and unpopulated tables and figures to be included in the primary and other secondary publications. DISCUSSION: Statistical analysis plan details what analyses will be done prior to unblinding to treatment allocation to avoid bias in the findings. Rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial will determine whether glyceryl trinitrate administered ultra-acutely can improve outcome after stroke. The rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 trial is registered as ISRCTN26986053.
Authors: Nikola Sprigg; Laura J Gray; Philip M W Bath; Gudrun Boysen; Peter Paul De Deyn; Pal Friis; Didier Leys; Reijo Marttila; Jan-Edwin Olsson; Desmond O'Neill; Bernd Ringelstein; Jan-Jacob van der Sande; Ewa Lindenstrøm Journal: J Hypertens Date: 2006-07 Impact factor: 4.844
Authors: Mark Willmot; Andrew Ghadami; Beverly Whysall; Wim Clarke; Joanna Wardlaw; Philip M W Bath Journal: Hypertension Date: 2006-05-08 Impact factor: 10.190
Authors: Myzoon Ali; Philip M W Bath; John Curram; Stephen M Davis; Hans-Christoph Diener; Geoffrey A Donnan; Marc Fisher; Barbara A Gregson; James Grotta; Werner Hacke; Michael G Hennerici; Marc Hommel; Markku Kaste; John R Marler; Ralph L Sacco; Philip Teal; Nils-Gunnar Wahlgren; Steven Warach; Christopher J Weir; Kennedy R Lees Journal: Stroke Date: 2007-04-19 Impact factor: 7.914
Authors: Bronwyn Tunnage; Lisa J Woodhouse; Mark Dixon; Craig Anderson; Sandeep Ankolekar; Jason Appleton; Lesley Cala; Timothy England; Kailash Krishnan; Diane Havard; Grant Mair; Keith Muir; Steve Phillips; John Potter; Christopher Price; Marc Randall; Thompson G Robinson; Christine Roffe; Else Sandset; Niro Siriwardena; Polly Scutt; Joanna M Wardlaw; Nikola Sprigg; Philip M Bath Journal: BMC Emerg Med Date: 2022-01-10
Authors: Philip M Bath; Lisa J Woodhouse; Kailash Krishnan; Jason P Appleton; Craig S Anderson; Eivind Berge; Lesley Cala; Mark Dixon; Timothy J England; Peter J Godolphin; Trish Hepburn; Grant Mair; Alan A Montgomery; Stephen J Phillips; John Potter; Chris I Price; Marc Randall; Thompson G Robinson; Christine Roffe; Peter M Rothwell; Else C Sandset; Nerses Sanossian; Jeffrey L Saver; A Niroshan Siriwardena; Graham Venables; Joanna M Wardlaw; Nikola Sprigg Journal: Stroke Date: 2019-10-07 Impact factor: 7.914